0000899243-19-005262.txt : 20190228 0000899243-19-005262.hdr.sgml : 20190228 20190228170519 ACCESSION NUMBER: 0000899243-19-005262 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190226 FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knappertz Volker CENTRAL INDEX KEY: 0001754122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 19644608 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON CITY: CAMBRIDGE STATE: X0 ZIP: CB249BZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-26 0 0001351288 GW PHARMACEUTICALS PLC GWPH 0001754122 Knappertz Volker SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ UNITED KINGDOM 0 1 0 0 Chief Medical Officer Ordinary Shares 2019-02-26 4 M 0 8436 0.0013 A 16608 D Ordinary Shares 2019-02-26 4 S 0 504 12.44 D 16104 D Ordinary Shares 2019-02-26 4 S 0 3600 12.46 D 12504 D Ordinary Shares 2019-02-26 4 S 0 36 12.29 D 12468 D Stock Options 0.0013 2019-02-26 4 M 0 8436 0.00 D 2019-02-26 2020-03-15 Ordinary Shares 8436 6 D Exercise of stock options. Following the exercise, these shares were converted into 703 American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019. These ordinary shares are represented by ADSs. The price reported in Column 4 is price per ordinary share converted from price per ADS. /s/ Volker Knappertz 2019-02-28